Влияние аффективных расстройств на течение ишемической болезни сердца: современная модель патогенеза депрессии, патофизиологические и поведенческие механизмы

1. Соболева Г.Н., Ерпылова Е.А., Рябыкина Г.В. и др. Влияние депрессивного состояния на показатели вариабельности ритма сердца у больных с ишемической болезнью сердца и коррекция выявленных нарушений с помощью терапии антидепрессантом тианептином. Кардиология. 2006; 11: 4–8.
2. Васюк Ю.А., Довженко Т.В. и др. Депрессивные и тревожные расстройства в кардиологии. М.: Анахарсис, 2009.
3. Смулевич А.Б., Дубницкая Э.Б., Дробижев М.Ю. и др. Депрессии и возможности их лечения в общемедицинской практике (предварительные результаты программы ПАРУС). Психич. расстройства в общей медицине. 2007; 2: 23–5.
4. Дробижев М.Ю. Лечение депрессий в общесоматической сети. Психиатр. и психофармакотер. 2003; 5 (5): 8–12.
5. Корнетов Н.А., Лебедева Е.В. Депрессивные расстройства у пациентов, перенесших инфаркт миокарда. Психиатр. и психофармакотер. 2003; 5: 195–8.
6. Нонка Т.Г. Клиническое течение ишемической болезни сердца, вариабельность ритма сердца, структурные изменения головного мозга у больных с перенесенным инфарктом миокарда в сочетании с депрессией. Томск: LUNA GROUP, 2011.
7. Сыркин А.Л., Смулевич А.Б., Дробижев М.Ю. и др. Особенности патогенеза, клиники и течения психогенно провоцированных инфарктов миокарда. Клин. медицина. 2005; 2: 30–3.
8. Погосова Г.В. Современные подходы к диагностике и лечению расстройств депрессивного спектра в общемедицинской практике. Кардиоваск. терапия и профилактика. (Прил.). 2007; 1.
9. Репин А.Н., Лебедева Е.В., Сергиенко Т.Н. Клиническое течение заболевания у пациентов с ИБС в сочетании с тревожно-депрессивными расстройствами на фоне длительной терапии антидепрессантами. Сиб. мед. журн. 2010; 25 (7): 2: 20–5.
10. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: МИА, 2003.
11. Сыркин А.Л. Ишемическая болезнь сердца и соматизированные депрессии: особенности клиники, дифференциальной диагностики и терапевтических подходов. Cons. Med. (Экстравыпуск). 2002; с. 7–9.
12. Тювина Н.А. Современные представления о патогенезе депрессии и подходы к антидепрессивной терапии. Психиатр. и психофармакотер. 2009; 4: 35–8.
13. Чазов Е.И. Депрессия как фактор развития и прогрессирования сердечно-сосудистых заболеваний. Сердечная недостаточность. 2003; 4 (1): 6.
14. Scherrer JF, Xian H, Bucholz KK et al. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosomatic Med 2003; 65: 548–57.
15. Broadley AJM, Korszun A, Jones CJH et al. Arterial endothelial function is impaired in treated depression. Heart 2002; 88: 521–3.
16. Panagiotakos DB, Pitsavos C, Chrysohoou C et al. ATTICA study. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease free people; the ATTICA study. Eur Heart J 2004; 25: 492–9.
17. Blumenthal JA. Depression and coronary heart disease: association and implications for treatment. Cleve Clin J Med 2008; 75 (Suppl. 2): S48–53.
18. Krantz D, Helmers K, Bairey CN et al. Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary artery disease. Psychosomatic Med 1991; 53: 1–12.
19. Parissis JT, Adamopoulos S, Rigas A et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with vs. without symptoms of depression. Am J Cardiol 2004; 94: 1326–8.
20. Sorensen C, Brandes A, Thrane J et al. Depression and acute coronary syndrome, prevalence and significance for survival. Eur Heart J 2000; 21: 212.
21. Carney RM, Blumenthal JA, Stein PK et al. Depression, heart rate variability and acute myocardial infarction. Circulation 2001; 104: 2024–8.
22. Dinan TG. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinol 1997; 22 (4): 261–7.
23. Taylor CB, Youngblood ME, Catellier D et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. ENRICHD trial. Arch Gen Psychiat 2005; 62: 792–8.
24. Robert MC, Phyllis KS, Lana LW et al. Effects of depression on Q–T interval variability after myocardial infarction psychocomatic. Medicine 2003; 65: 177–80.
25. Kanel Von R, Mills P, Fainman C et al. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001; 63: 531–44.
26. Laghrissi-Thode F, Wagner WR, Pollock BG et al. Elevated platelet factor 4 and b-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiat 1997; 42: 290–5.
27. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehab 2003; 4: S1.
28. Meredith IT, Broughton A, Jennings GL et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325: 618–24.
29. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049–53.
30. Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiat 2003; 60 (6): 627–36.
31. Giubbini R. Effects of mental stress on myocardial perfusion in patients with ischemic heart disease. Circulation 1991; 83 (Suppl. 2): 100–7.
32. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000; 140: S77–83.
33. Gottdiener JS. Induction of silent myocardial ischemia with mental stress testing: relation to the triggers of ischemia during daily life activities and to ischemic functional severity. J Am Coll Cardiol 1994; 24: 1645–51.
34. Krittayaphong R, Cascio WE, Light KC et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosomatic Med 1997; 59: 231–5.
35. Schins A, Hogin A, Crijns H et al. Increased coronary events in depressed cardiovascular patients: 5-HT2a receptor as missing link. Psychocomatic Med 2003; 65: 729–37.
36. Yeragani VK, Pohl R, Jampala VC et al. Increased  Q–T variability in patients with panic disorder and depression. Psychiatry Res 2000; 93: 225–35.
37. Goldberg AD, Becker LC, Bonsall R et al. Ischemic, hemodynamic, and neurohormonal responses to mentel and exercise stress. Experience from the Psychophysioligical Investigations of Myocardial Ischemia Study (PIMI). Circulation 1996; 94: 2402–9.
38. Jackson IM. The thyroid axis and depression. Thyroid 1998; 8: 951–6.
39. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991; 12: 118–34.
40. Kop WJ. Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses. J Am Coll Cardiol 2001; 37 (5): 1359–66.
41. Kusumi I, Koyama T, Yamashita I. Serotonin-stimulated Ca response is increased in the blood platelets of depressed patients. Biol Psychiat 1991; 30: 310–2.
42. O'Malley PG, David LJ, Irwin MF et al. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med 2000; 343: 1298–304.
43. Young-Xu Y, Chan KA, Liao JK et al. Longterm statin use and psychological wellbeing. J Am Coll Cardiol 2003; 42: 690–7.
44. Luukinen H, Laippala P, Huikuri HV. Depressive symptoms and the risk of sudden cardiac death among the elderly. Eur Heart J 2003; 24: 2021–6.
45. Manji HK, Drevents WC, Charney DC. The cellur neurobiology of depression. Nat Med 2001; 7: 541–7.
46. Pasic J. Cytokines in depression and heart failure. Psychosom Med 2003; 65: 181–93.
47. Padney GN, Padney SC, Janiac PG et al. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiat 1990; 28: 215–22.
48. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression Hypothalamic-pituitary-adrenalais. Psychiatr Clin N Am 1998; 21: 293–307.
49. Thombs BD, Bass EB, Ford DE еt al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21 (1): 30–8.
50. Sykes DH, Arveiler D, Salters CP et al. Psychosocial risk factors for heart disease in France and Northern Ireland: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Int J Epidemiol 2002; 31: 1227–34.
51. Nahsoni E, Aizenberg D, Strasberg B et al. Q–T dispersion in the surface electrocardiogram in elderly patients with major depression. J Affective Disorder 2000; 60: 197–200.
52. Redwine LS. Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in failure patients. Psychosom Med 2007; 69: 23–9.
53. Agelik MW, Boz C, Ullrich H et al. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiat Res 2002; 113: 139–49.
54. Jiang W, Alexander J, Christopher E et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849–56.
55. Wyatt RJ, Portnoy B, Kupfer DJ et al. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiat 1971; 24: 65–70.
56. Rozanski A, James AB, Kaplan J. Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy. Circulation 1999; 99: 2192–217.
57. Strouse TB. The relationship between cytokines and pain/depression: a review and current status. Curr Pain Headache Rep 2007; 11: 98–103.
58. Veith RC, Lewis L, Linares OA et al. Sympathetic nervous system activity in major depression: basal and desipramine induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiat 1994; 51: 411–22.
59. Dakak N, Quyyumi AA, Eisenhofer G et al. Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol 1995; 76: 125–30.
60. Boldoueva S, Shabrov A, Trofimova O, Zhuk V. The influence of psychological factors on heart rate variability after myocardial infarction. Europ Heart J 2003; 24: 947.
61. Carney RM, Freedland KE, Rich MW et al. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95: 23–8.
62. Walkins LL, Grossman P. Аssociation of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999; 137: 453–7.
63. William RL, William G. Psychophysiological reactivity: mechanisms and pathways to cardiovascular disease. Psychosomatic Med 2003; 65: 36–45.

Т.Г.Нонка*, А.Н.Репин, Т.Н.Сергиенко

ФГБУ Научно-исследовательский институт кардиологии Сибирского отделения РАН, Томск
*ntg@sibmail.com

________________________________________________

T.G.Nonka*, A.N.Repin, T.N.Sergienko

Cardiology Research Institute, Siberian Branch of the Academy of Sciences, Tomsk
*ntg@sibmail.com